ArticleFrontiers in endocrinology2024

Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors.

Virginie Jacques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.